Skip to main content
Clinical Trials/NCT05318235
NCT05318235
Completed
Not Applicable

Virus Interactions in the Respiratory Tract; a Cohort Study With Children

UMC Utrecht1 site in 1 country229 target enrollmentSeptember 15, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Respiratory Tract Infections
Sponsor
UMC Utrecht
Enrollment
229
Locations
1
Primary Endpoint
Strength of viral interactions
Status
Completed
Last Updated
last year

Overview

Brief Summary

Rationale: Prevention of virus induced acute respiratory infection (ARI) is a public health priority. As different respiratory virus infections can interact with each other, occurrence of one virus may influence occurrence of other virus infections. Such interactions can have implications for the effects of vaccination on non-target diseases. In this project, we will quantify such interactions between respiratory viruses by longitudinally studying a cohort of young children.

Objective: To quantify the strength and direction of interactions between important respiratory virus infections in young children.

Study design: This is a prospective observational cohort study.

Study population: Children between 6 weeks and 4 years of age residing in the Utrecht area of the Netherlands.

Main study parameters/endpoints: Frequency, timing and sequences of occurrence of respiratory virus infections will be studied for each participant using weekly collected nasal specimens during 16 weeks follow-up. Detection will be based on PCR testing for a panel of common respiratory viruses. From these data, estimation of virus interaction parameters will be based on self-controlled-case series analysis.

Nature and extend of the burden and risks associated with participation, benefit and group relatedness: This study is observational in nature. There will be no direct benefit to research participants. The study includes biological sampling. The results of the tests done on these samples may not contribute to improving the participant's health. Minimal inconvenience and discomfort to the participant may arise from study visits and biological sampling.

Registry
clinicaltrials.gov
Start Date
September 15, 2021
End Date
April 23, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Patricia Bruijning-Verhagen

Principal investigator

UMC Utrecht

Eligibility Criteria

Inclusion Criteria

  • Age between 6 weeks and 4 years AND
  • have older siblings or 2) attend daycare. AND
  • Live within 30 minutes drive from UMCU (by car), have access to a fever thermometer and a freezer were biological samples can be temporarily stored

Exclusion Criteria

  • recurrent respiratory tract infections and are treated with antibiotic prophylaxis OR
  • known immunodeficiency OR
  • chronic lung disease that increases susceptibility to infection (e.g. cystic fibrosis) OR
  • congenital anomalies of the airways
  • Parents/guardians have insufficient comprehension of Dutch language (all study communication and questionnaires are in Dutch language)

Outcomes

Primary Outcomes

Strength of viral interactions

Time Frame: Samples and data collected during 16 weeks of follow-up

To quantify the strength of interactions between common respiratory virus infections in young children.

Direction of viral interactions

Time Frame: Samples and data collected during 16 weeks of follow-up

To quantify the direction of interactions between common respiratory virus

Secondary Outcomes

  • To estimate the probability of symptomatic versus asymptomatic infection per respiratory virus and host factors influencing this.(Samples and data collected during 16 weeks of follow-up)
  • To quantify the changes in viral exposure in the pandemic-to-post-pandemic transition period and study effects of these changes on viral interaction patterns(Samples and data collected during 16 weeks of follow-up)
  • To quantify relative change in disease severity due to viral interactions.(Samples and data collected during 16 weeks of follow-up)
  • To estimate the seasonal incidence rates of both symptomatic and asymptomatic infection by common respiratory viruses in young children(Samples and data collected during 16 weeks of follow-up)

Study Sites (1)

Loading locations...

Similar Trials